SecBot SecBot
SECBOTREPLAY Home › Report › IRWD

IRWD · Six open-market share sales by three C-suite executives at Ironwood…

IRONWOOD PHARMACEUTICALS INC · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Six open-market share sales by three C-suite executives at Ironwood Pharmaceuticals (IRWD) over the past seven days totaled approximately $958,000. The CEO, CFO, and Chief Legal Officer collectively sold over 237,000 shares at prices between $3.66 and $3.81 per share, indicating coordinated insider selling.

  • CEO Thomas McCourt sold 198,283 shares for $739,929.33 over two days (Feb 23–24, 2026).
  • CFO Gregory Martini sold 21,944 shares for $81,888.09.
  • Chief Legal Officer John Minardo sold 36,492 shares for $136,176.57.
  • All transactions were open-market sales (Form 4 'S' codes), not related to grants, taxes, or derivatives.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access